Gastrointestinal symptoms are among the most common side effects when using GLP-1 medications, such as FDA-approved Ozempic, Wegovy, and Rybelsus
2021 Jan 6;11(1):2
Theyve basically said, look, we understand we want to build the future, and we dont just want the future be built on top of us
This evidence-based guide examines: The pharmacology and mechanism of GLP-1 receptor agonists Whether delayed gastric emptying affects nutrient absorption How sustained appetite suppression may alter micronutrient density Protein intake and lean mass preservation during rapid weight loss Nutrients of potential concern (iron, vitamin B12, folate, magnesium, calcium, vitamin D, fat-soluble vitamins, electrolytes and zinc) Clinical monitoring strategies and laboratory markers Dietary and supplementation considerations grounded in current evidence Current literature does not support the claim that GLP-1 medications universally cause micronutrient deficiencies
Simply put, it mirrors the effects of a naturally occurring hormone that orchestrates blood sugar levels and appetite
